ESI-08 is a potent and selective EPAC antagonist that completely inhibits both EPAC1 and EPAC2 activity (IC50 = 8.4 μM for EPAC2) without inhibition of cAMP-mediated PKA activation.
Products > Drug Discovery > Inhibitor > Other Inhibitors | Products > Drug Discovery > Inhibitor
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.
日本语
한국어
Français
Deutsch
España
Türkiye